IMPORTANCE Studies of neurological deterioration in stroke have focused on the subacute period, but stroke treatment is increasingly migrating to the prehospital setting, where the neurological course has not been well delineated.
F or both acute cerebral ischemia (ACI) and acute intracranial hemorrhage (ICH), neurological progression following first symptom onset is a common and feared complication. However, the frequency, predictors, and outcomes of neurological deterioration in the ultra-early time window (3-4 hours), including the prehospital period, have not been well characterized. Instead, studies have generally examined neurological deterioration across extended time windows after hospital arrival, including at any time during the initial hospitalization, 1, 2 or have examined early neurological deterioration (END), defined as within 48 hours of admission.
3,4
Although 1 study investigated prehospital deterioration among patients with intracerebral hemorrhage, 5 we know of no systematic studies of ultra-early neurological deterioration (U-END) in both the prehospital and initial emergency department (ED) phase encompassing both patients with ACI and those with acute ICH. Many interventions for treatment of acute stroke are most effective when initiated as soon as possible after stroke onset. [6] [7] [8] [9] [10] [11] As a result, both delivery of standard treatments and research studies of experimental treatments are increasingly migrating to the early postarrival ED time period or directly to the prehospital phase of care. [12] [13] [14] [15] [16] The earliest point from which neurological deterioration can be systematically studied is the initial assessment by emergency medical services personnel prior to transport. The prehospital phase of stroke typically lasts 25 to 40 minutes from emergency medical services arrival on the scene to completion of transport to the ED. While in the ED, another 30 to 60 minutes are spent in triage, initial stabilization, transport to neuroimaging, and imaging interpretation prior to starting stroke subtype-specific therapy. 17 There is an urgent need to characterize the frequency, predictors, and outcomes of neurological deterioration among patients in these earliest time windows for use as a baseline against which faster delivery methods and novel treatments can be assessed, to identify patients at greatest risk of U-END so that they can receive the fastest standard treatment, and to enrich enrollment in clinical trials of progression-averting research interventions.
Methods
This was an exploratory analysis of patients enrolled in the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) Trial, a phase 3, National Institute of Neurological Disorders and Stroke-sponsored, placebo-controlled randomized clinical trial of field-initiated magnesium sulfate in patients with hyperacute stroke within 2 hours after the last known well time (LKWT) conducted from 2005 to 2013. 16, 18, 19 Participating sites included 40 emergency medical system agencies, 315 ambulances, and 60 acute care receiving hospitals in Los Angeles and Orange counties in California. The study protocol was approved by the institutional review board at each prehospital and hospital study site. Enrollment occurred using explicit informed consent obtained via cellphone conversation between patients on the scene or their legally authorized representatives and enrolling physician-investigators off the scene or under exception from informed consent regulations.
20,21
Neurological deterioration was defined as worsening by 2 or more points on the Glasgow Coma Scale (GCS; range, 3-15, with higher numbers indicating alertness).
5 The FAST-MAG Trial patients had up to 3 serial GCS evaluations in the ultraearly time period: the first during the initial prehospital assessment (performed by paramedics), the second at the initial ED arrival (performed by ED bedside nurses), and the third early in the ED course (performed by FAST-MAG research nurses). The prehospital and early ED course GCS evaluations were mandated by the study protocol and performed in nearly all patients. The ED arrival GCS evaluation was not required by the study protocol but was commonly performed as part of routine clinical practice at participating hospitals. Accordingly, the occurrence of U-END was assessed for all patients between the prehospital and shortly postarrival GCS evaluations. For patients with a clinically documented ED arrival GCS assessment, additional analyses were performed assessing U-END occurrence in the prehospital phase (between the prehospital and ED arrival assessments) and U-END occurrence in the early postarrival phase (between the ED arrival and ED course assessments) (eFigure in the Supplement). Specific patterns of deficit progression were identified as follows: prehospital sustained indicated prehospital deterioration and then a stable early ED phase; dipper indicated prehospital deterioration and then early ED improvement; delayed indicated stable prehospital and then ED deterioration; peaker indicated prehospital improvement and then early ED deterioration; continuous major indicated prehospital deterioration and early ED deterioration; and continuous minor indicated mild (1 point) GCS score worsening in both prehospital and early ED phases, cumulatively reaching the threshold for deterioration. Prehospital ambulance services and hospital receiving sites were directed to provide supportive treatment and blood pressure control as well as thrombolytic, endovascular, and surgical care according to the national American Heart Association/ American Stroke Association guidelines for care of patients with acute ischemic stroke or intracerebral hemorrhage in addition to the study treatment of an infusion of magnesium sulfate or placebo. Throughout the study region in accordance with the predominant US emergency medical services practice, administration of antihypertensive therapies was not initiated in the field but deferred to ED arrival if needed.
All modified Rankin Scale assessments (scores range from 0 to 6, with higher numbers indicating greater disability) were performed by physician and nurse raters certified in the validated Rankin Focused Assessment method for assigning modified Rankin Scale scores. Additional study-specific training on the use of the GCS was not performed because GCS scoring is a core competency of paramedics, neurologists, and emergency department physicians and nurses.
Statistical analysis of associations used χ 2 tests for binary variables and t tests for linear variables. Two-sided P ≤ .05 values were considered statistically significant. Because all analyses were considered exploratory, no adjustment for multiplicity was made. A multivariate prediction model for occurrence of neurological deterioration was derived by stepwise logistic regression using variables with univariate P ≤ .05 values as candidates. Data analyses were performed using SPSS, version 20 (SPSS Inc).
Results
Among the 1700 patients enrolled in the FAST-MAG Trial, 1690 patients (99.4%) had serial GCS assessments performed at the 2 protocol-mandated times of prehospital and early ED course (10 patients were excluded for 1 or more missing GCS scores). This population constituted the primary analytic population for the present study. Among these 1690 patients, the mean (SD) age was 69.4 (13.5) years, 725 patients (43%) were female, and the final diagnosis was ACI in 1237 patients (73.2%), acute ICH in 386 patients (22.8%), and cerebrovascular mimic in 67 patients (4.0%). The median time from LKWT to the initial paramedic GCS assessment was 23 minutes (interquartile range [IQR], 14-42 minutes), the median LKWT to ED arrival was 58 minutes (IQR, 46-79 minutes), the median LKWT to early ED course GCS assessment was 149 minutes (IQR, , and the median time from prehospital GCS assessment to early ED course GCS assessment was 117 minutes (IQR, 95-143 minutes) ( Table 1) . Ultra-early neurological deterioration between prehospital paramedic evaluation and the early ED course evaluation occurred in 200 of 1690 patients (11.8%). Univariate predictors of U-END among all enrolled patients were Asian race, Hispanic ethnicity, history of hypertension, absence of history of atrial fibrillation or valvular heart disease, higher prehospital systolic and diastolic blood pressure, more severe prehospital focal motor deficits on the Los Angeles Motor Scale (LAMS), and a final diagnosis of acute ICH rather than ACI (Table 2 and eTable 4intheSupplement). In multivariate analyses, independent predictors of U-END were prehospital GCS assessment (odds ratio [OR] , 0.7 per point increase; 95% CI, 0.7-0.8) and final diagnosis of acute ICH (OR, 3.9; 95% CI, 1.6-9.5).
Among patients who received a final diagnosis of ACI, U-END occurred in 75 of 1237 patients (6.1%). Univariate predictors of U-END among patients with ACI were female sex, history of diabetes, alcohol abstinence, and more severe stroke deficits as assessed by both the GCS and the LAMS (Table 2 ). In addition, systolic blood pressure was nominally lower among patients with ACI and deterioration (153.6 vs 155.8, P = .06). Among patients who received a final diagnosis of ICH, U-END occurred in 119 of 386 patients (30.8%). Univariate predictors of U-END among patients with ICH were history of hypertension, coronary artery disease, myocardial infarction, and more severe stroke deficits as assessed by both the GCS and the LAMS (Table 2 ). In addition, systolic blood pressure at ED arrival, although not prehospital, was higher among patients with U-END.
More detailed analysis of the timing of deficit evolution was performed in the 965 patients (56.8%) who had an ED arrival GCS score documented as part of their routine care. Patients with or without a clinically performed ED arrival GCS assessment were similar in baseline characteristics and outcomes (eTable 1 in the Supplement). Among these patients, the median time from prehospital GCS assessment to ED arrival GCS assessment was 46 minutes (IQR, 37-59 minutes) and from ED arrival GCS assessment to early ED course GCS assessment was 70 minutes (IQR, 45-95 minutes) ( Table 1) .
Among all patients with an ED arrival GCS assessment, 93 of 965 patients (9.6%) experienced U-END only en route to the hospital, 83 of 965 patients (8.6%) experienced U-END only between the ED arrival and early ED course GCS assessments, and 23 of 965 patients (2.4%) experienced U-END in both phases. The results of a multivariate analysis indicated that the only independent predictor of prehospital U-END was receiving a final diagnosis of ICH (OR, 3.5; 95% CI, 2.3-5.3). For postarrival U-END, receiving a final diagnosis of ICH independently increased the likelihood (OR, 6.1; 95% CI, 3.8-9.8), whereas the occurrence of prehospital U-END independently decreased the likelihood (OR, 0.64; 95% CI, 0.7-0.8). Among 713 patients with cerebral ischemia, 128 patients (18.0%) had U-END, including 64 patients (8.9%) in the prehospital phase only, 52 patients (7.3%) in the early ED phase only, and 1 (0.2%) in both phases. Among 210 patients with ICH, 82 patients (39.0%) had U-END, including 27 patients (12.9%) in the prehospital phase only, 30 patients (14.3%) in the early ED phase only, and 22 patients (10.5%) in both phases. More detailed patterns of deficit progression are shown in eTables 2 and 3 in the Supplement and in Figure 1 and Figure 2 .
The occurrence of U-END was associated with worse early stroke outcomes (Table 3) . Early intubation (intubation by the time of the early postarrival ED assessment) and in-hospital mortality were more frequent among patients with U-END than among those without U-END. Among patients with ACI, the extent of the acute ischemic change on first imaging, assessed using the Alberta Stroke Program Early Computed Tomographic Score, was higher among patients with U-END than among patients without U-END. Among patients with intraparenchymal hemorrhages, hematoma volume on first imaging was higher among patients with U-END than among patients without U-END. The occurrence of U-END was also strongly associated with worse final clinical outcome (Table 3) . For example, among all 1690 patients, rates of good functional outcome (modified Rankin Scale score of 0-2) at 3 months after stroke were 16.0% (32 of 200) among individuals with U-END and 56.6% (844 of 1490) among individuals without U-END (P < .001). Rates of good functional outcome among patients with cerebral ischemia were 24.0% (18 of 75) among those with U-END vs 59.8% (695 of 1162) among those without U-END (P < .001), and among patients with ICH, the rates were 8.4% (10 of 119) among those with U-END vs 39.7% (106 of 267) among those without U-END (P < .001). Three-month mortality rates among patients with U-END were 87 of 200 (43.5%) vs 176 of 1490 (11.8%) among those without U-END (P < .001), including 29 of 75 patients (38.7%) with cerebral ischemia and with U-END vs 124 of 1162 patients (10.7%) without U-END (P < .001) and 58 of 119 patients (48.7%) with ICH and with U-END vs 45 of 267 patients (16.9%) without U-END (P < .001). The distribution of 3-month disability outcomes among patients by detailed U-END pattern categories is shown in Figure 2 .
Discussion
This study found that neurological deterioration as assessed with the GCS in the ultra-early period was frequent among ambulance-transported patients with acute cerebrovascular disease, occurring in 12% of patients. Ultra-early neurological deterioration was substantially more common among patients with ICH, occurring in nearly 1 in 3 of such patients, and less common but still notable among patients with ACI, occurring in about 1 in 16 of these patients. Among all patients with acute cerebrovascular disease, independent predictors of U-END were ICH stroke subtype and lower initial prehospital GCS score.
To our knowledge, this study is the first prospective, multicenter investigation of clinical deterioration in the prehospital and early ED course during the first minutes and hours after symptom onset in a broad cerebrovascular disease cohort. For ACI, prior studies of neurological deterioration have focused solely on later in-hospital time windows. For example, in a systematic meta-analysis and later large caseseries studies, the 8 studies reporting on the frequency of neurological deterioration due to stroke progression had observation periods that were not always well demarcated but that appeared to begin 3 to 72 hours after stroke onset and end 24 to 168 hours after stroke onset. [22] [23] [24] [25] [26] [27] [28] [29] In these case series, neurological worsening occurred in a median of 9.6% (IQR, 5.1%-18.1%) of patients. In the present study in a much earlier and more compressed window of median observation times between 0.4 and 2.5 hours after onset, U-END occurred in 6.1% of patients with ischemic stroke. For acute ICH, most prior studies have also focused on neurological deterioration occurring within 24 hours of ED arrival. [30] [31] [32] Current large studies analyzing deterioration among patients with ICH after hospital arrival have considered periods from 5 to 28 hours after the LKWT, 31 from 1.5 to 25.5 hours, 32 from up to 6 hours to 72 hours, 30 and from a median of 7.3 hours to 9 to 13 hours after the LKWT. 33, 34 One prior single-center study did investigate the prehospital period in 98 patients with intracerebral hemorrhage and reported neurological deterioration in 22% of these patients. 5 Our study confirms and extends this finding in a larger multicenter cohort, documenting deterioration in 23% of patients with ICH in the prehospital setting as well as finding that deterioration additionally occurs in 24% of patients in the first minutes to hours after ED arrival. Among all patients with acute cerebrovascular disease transported by paramedics, there were only 2 independent predictors of neurological deterioration: more severe initial level of consciousness impairment as assessed by the GCS and a final stroke subtype diagnosis of ICH rather than ACI. Predictors of early neurological deterioration were largely different among patients with ACI and with ICH, although more severe initial deficits at the time of initial paramedic encounters were associated with deterioration in both stroke subtypes. Female sex and alcohol abstinence were associated with neurological deterioration in ACI, whereas history of hypertension and myocardial disease were associated with neurological deterioration in ICH. There was a suggestion of a differential association of blood pressure with progression among patients with ACI compared with those with ICH. Among patients with ACI, END tended to be associated with lower systolic blood pressure at the time of the first paramedic evaluation, whereas among patients with ICH, END tended to be associated with higher systolic blood pressure at ED arrival. Our findings on the association of prehospital and ED arrival blood pressure with END among patients with ICH are of interest given the nascent conduct of randomized trials of blood pressure lowering in the field. [35] [36] [37] Two prior observational studies have investigated aspects of this association. In a singlecenter study of 98 ICH cases, neurological deterioration in the field was associated with higher prehospital diastolic blood pressure but not with higher prehospital systolic blood pressure. 5 In another single-center study of 536 patients with ICH, neurological deterioration in the prehospital period was not examined, but neurological deterioration after hospital arrival was associated with higher prehospital diastolic and systolic blood pressures. 33 In the present study, END was associated with higher systolic blood pressure on ED arrival but not with higher prehospital blood pressures. The nonuniform but suggestive findings from these 3 observational studies support further formal trials of the therapeutic strategy of prehospital blood pressure moderation in patients likely to have ICH.
For prehospital system planning, the present study provides unique insight into the frequency of deterioration occurring between paramedic evaluation in the field and ED arrival. Our study findings indicated that emergency medical services system planners may anticipate that approximately 1 in 10 patients with stroke (including about 1 in 4 patients with acute ICH) will deteriorate between the scene and ED arrival. This frequency of prehospital deterioration reflects transport in a largely urban or suburban setting with relatively short transport times. In rural settings with longer transport times, the frequency of deterioration will be higher, as suggested by the 1 in 8 rate of deterioration in the present study between the scene and the later ED course evaluation.
The potential pathophysiologic mechanisms of U-END are varied. In ACI, causes of U-END may include reduction in collateral circulation, clot propagation, recurrent embolus, and hemorrhagic transformation of infarct. In acute intracerebral hemorrhage, causes of U-END may include hematoma expansion and obstructive hydrocephalus. The much larger hematoma volume observed on arrival imaging among patients with intraparenchymal hemorrhage and U-END, approximately twice the size of that among patients without U-END, suggests that hemorrhage expansion in the field and during the early ED course, prior to the collection of the first images, was likely an important contributor. In both ischemic and hemorrhagic stroke, U-END may also be caused by noncerebrovascular events, such as seizure, respiratory compromise, and myocardial infarction. These noncerebrovascular events were rare in the prehospital period, 16 but intubation for respiratory compromise or concern did occur early in the ED course in about 6 in 10 of the patients with ICH and U-END. The high frequency of U-END emphasizes the importance of migrating clinical trials for acute stroke into the prehospital setting so that treatments can be initiated at the earliest moment of medical contact in advance of U-END. 15, 16, [36] [37] [38] [39] [40] Limitations Our analysis included only those patients who were enrolled in a clinical trial. Although the FAST-MAG Trial entry criteria were broad in age, stroke severity, and comorbidities, 41 the study did exclude patients with prestroke disability, systolic blood pressure higher than 220, and other uncommon features. Such patients may have different frequencies of U-END. For example, patients with ICH and systolic blood pressure greater than 220 mm Hg may have higher rates of U-END. The present study, similar to prior prehospital investigations, 5,33 used a change in GCS scores to identify neurological deterioration and improvement. Because the GCS is a measure of the level of consciousness rather than the degree of focal deficit, it may not capture all clinically relevant deficit changes in patients. Studies of in-hospital neurological deterioration among patients with ACI have most often focused on a prespecified increase in the National Institutes of Health Stroke Scale score, 1 but assessments using this scale are too timeconsuming for routine use in the field by paramedics. The GCS has good interrater reliability and is universally used by prehospital personnel, making study findings of wide applicability. As in prior studies, the present investigation excluded patients who were already comatose at the time of first paramedic evaluation, as further worsening in these patients would have been difficult to detect. Comatose patients with ICH at the time of emergency medical services arrival are uncommon, but when such patients are included, rates of deterioration in the prehospital setting will be slightly lower than the current study estimates. Although initial brain imaging was obtained in all study patients, follow-up serial imaging was not mandated; thus, the present study cannot address the frequency of postarrival infarct growth or hemorrhage expansion. The timing of the early ED course GCS assessment was nonuniform; the median time was approximately 82 minutes, but the IQR was from about 61 to 108 minutes after ED arrival, which was caused by the variability in arrival time of the responding regional study nurse. The FAST-MAG Trial collected information on the timing of the start of antihypertensive medication administration, if any, after arrival. Some data on blood pressure medication use among patients with ICH were collected in a nonmonitored manner and will be analyzed in a future exploratory analysis.
Conclusions
Approximately 1 in 8 patients with suspected acute cerebrovascular disease experienced U-END as assessed with the GCS during paramedic transport and initial ED evaluation. Ultra-early neurological deterioration was more common among patients with ICH, occurring in nearly 1 in 3 of these patients, and less common but still frequent among patients with ACI, occurring in 1 in 16 of these patients. Patients with more severe initial deficits in the field had higher rates of U-END, and patients with U-END had substantially worse final functional outcomes and increased mortality. These findings suggest the desirability of initiating stroke therapies as soon as possible after stroke onset, including in the prehospital setting, to avert the occurrence of U-END. 
